Literature DB >> 24012120

Discovery and synthesis of novel benzofurazan derivatives as inhibitors of influenza A virus.

Ulrich Kessler1, Daniele Castagnolo, Mafalda Pagano, Davide Deodato, Martina Bernardini, Beatrice Pilger, Charlene Ranadheera, Maurizio Botta.   

Abstract

The identification of a novel hit compound inhibitor of the protein-protein interaction between the influenza RNA-polymerase PA and PB1 subunits has been accomplished by means of high-throughput screening. A small family of structurally related molecules has been synthesized and biologically evaluated with most of the compounds showing micromolar potency of inhibition against viral replication.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral agents; Benzofurazan; H1N1; Influenza virus; Viral RNA polymerase

Mesh:

Substances:

Year:  2013        PMID: 24012120     DOI: 10.1016/j.bmcl.2013.08.048

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  AZT acts as an anti-influenza nucleotide triphosphate targeting the catalytic site of A/PR/8/34/H1N1 RNA dependent RNA polymerase.

Authors:  Nataraj Sekhar Pagadala
Journal:  J Comput Aided Mol Des       Date:  2019-02-09       Impact factor: 3.686

2.  Irreversible binding of an anticancer compound (BI-94) to plasma proteins.

Authors:  Nagsen Gautam; Rhishikesh Thakare; Sandeep Rana; Amarnath Natarajan; Yazen Alnouti
Journal:  Xenobiotica       Date:  2015-04-14       Impact factor: 1.908

Review 3.  Antiviral strategies against influenza virus: towards new therapeutic approaches.

Authors:  Arianna Loregian; Beatrice Mercorelli; Giulio Nannetti; Chiara Compagnin; Giorgio Palù
Journal:  Cell Mol Life Sci       Date:  2014-04-04       Impact factor: 9.261

Review 4.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.

Authors:  Annelies Stevaert; Lieve Naesens
Journal:  Med Res Rev       Date:  2016-08-29       Impact factor: 12.944

5.  Structure-based drug discovery for combating influenza virus by targeting the PA-PB1 interaction.

Authors:  Ken Watanabe; Takeshi Ishikawa; Hiroki Otaki; Satoshi Mizuta; Tsuyoshi Hamada; Takehiro Nakagaki; Daisuke Ishibashi; Shuzo Urata; Jiro Yasuda; Yoshimasa Tanaka; Noriyuki Nishida
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

Review 6.  Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins.

Authors:  Lingxin Hou; Ying Zhang; Han Ju; Srinivasulu Cherukupalli; Ruifang Jia; Jian Zhang; Bing Huang; Arianna Loregian; Xinyong Liu; Peng Zhan
Journal:  Acta Pharm Sin B       Date:  2021-11-19       Impact factor: 14.903

7.  The interaction between the Nipah virus nucleocapsid protein and phosphoprotein regulates virus replication.

Authors:  Charlene Ranadheera; Roxanne Proulx; Mark Chaiyakul; Shane Jones; Allen Grolla; Anders Leung; John Rutherford; Darwyn Kobasa; Michael Carpenter; Markus Czub
Journal:  Sci Rep       Date:  2018-10-30       Impact factor: 4.379

8.  Anti-influenza A virus activity and structure-activity relationship of a series of nitrobenzoxadiazole derivatives.

Authors:  Francesco Fiorentino; Marta De Angelis; Martina Menna; Annarita Rovere; Anna Maria Caccuri; Francesca D'Acunzo; Anna Teresa Palamara; Lucia Nencioni; Dante Rotili; Antonello Mai
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.